These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37329450)

  • 1. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation.
    Hummel S; Carl J; Friedl N; Winkler C; Kick K; Stock J; Reinmüller F; Ramminger C; Schmidt J; Lwowsky D; Braig S; Dunstheimer D; Ermer U; Gerstl EM; Weber L; Nellen-Hellmuth N; Brämswig S; Sindichakis M; Tretter S; Lorrmann A; Bonifacio E; Ziegler AG; Achenbach P;
    Diabetologia; 2023 Sep; 66(9):1633-1642. PubMed ID: 37329450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany.
    Ziegler AG; Kick K; Bonifacio E; Haupt F; Hippich M; Dunstheimer D; Lang M; Laub O; Warncke K; Lange K; Assfalg R; Jolink M; Winkler C; Achenbach P;
    JAMA; 2020 Jan; 323(4):339-351. PubMed ID: 31990315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.
    Weiss A; Zapardiel-Gonzalo J; Voss F; Jolink M; Stock J; Haupt F; Kick K; Welzhofer T; Heublein A; Winkler C; Achenbach P; Ziegler AG; Bonifacio E;
    Diabetologia; 2022 Dec; 65(12):2121-2131. PubMed ID: 36028774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies.
    Winkler C; Schober E; Ziegler AG; Holl RW
    Pediatr Diabetes; 2012 Jun; 13(4):308-13. PubMed ID: 22060727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
    McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
    Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study.
    Raab J; Haupt F; Scholz M; Matzke C; Warncke K; Lange K; Assfalg R; Weininger K; Wittich S; Löbner S; Beyerlein A; Nennstiel-Ratzel U; Lang M; Laub O; Dunstheimer D; Bonifacio E; Achenbach P; Winkler C; Ziegler AG;
    BMJ Open; 2016 May; 6(5):e011144. PubMed ID: 27194320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes.
    Hendriks AEJ; Marcovecchio ML; Besser REJ; Bonifacio E; Casteels K; Elding Larsson H; Gemulla G; Lundgren M; Kordonouri O; Mallone R; Pociot F; Szypowska A; Toppari J; Berge TVD; Ziegler AG; Mathieu C; Achenbach P;
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3777. PubMed ID: 38375753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and demographic features among patients with type 1 diabetes mellitus in Henan, China.
    Yang L; Yang G; Li X
    BMC Endocr Disord; 2021 Jun; 21(1):131. PubMed ID: 34176476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up.
    Lundgren M; Sahlin Å; Svensson C; Carlsson A; Cedervall E; Jönsson B; Jönsson I; Larsson K; Lernmark Å; Neiderud J; Vigård T; Elding Larsson H;
    Pediatr Diabetes; 2014 Nov; 15(7):494-501. PubMed ID: 24823816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Long-Term Comparison of Presenting Characteristics of Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic.
    Kaya G; Cimbek EA; Yeşilbaş O; Bostan YE; Karagüzel G
    J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):267-274. PubMed ID: 35308015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany.
    Karl FM; Winkler C; Ziegler AG; Laxy M; Achenbach P
    Diabetes Care; 2022 Apr; 45(4):837-844. PubMed ID: 35156126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control.
    Duca LM; Wang B; Rewers M; Rewers A
    Diabetes Care; 2017 Sep; 40(9):1249-1255. PubMed ID: 28667128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries.
    Birkebaek NH; Kamrath C; Grimsmann JM; Aakesson K; Cherubini V; Dovc K; de Beaufort C; Alonso GT; Gregory JW; White M; Skrivarhaug T; Sumnik Z; Jefferies C; Hörtenhuber T; Haynes A; De Bock M; Svensson J; Warner JT; Gani O; Gesuita R; Schiaffini R; Hanas R; Rewers A; Eckert AJ; Holl RW; Cinek O
    Lancet Diabetes Endocrinol; 2022 Nov; 10(11):786-794. PubMed ID: 36202118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
    Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
    Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Long-term HbA1c in 7,961 Children and Young Adults in the Australasian Diabetes Data Network.
    Clapin HF; Earnest A; Colman PG; Davis EA; Jefferies C; Anderson K; Chee M; Bergman P; de Bock M; Kao KT; Fegan PG; Holmes-Walker DJ; Johnson S; King BR; Mok MT; Narayan K; Peña Vargas AS; Sinnott R; Wheeler BJ; Zimmermann A; Craig ME; Couper JJ;
    Diabetes Care; 2022 Dec; 45(12):2918-2925. PubMed ID: 36749868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes.
    Thomas NJ; Lynam AL; Hill AV; Weedon MN; Shields BM; Oram RA; McDonald TJ; Hattersley AT; Jones AG
    Diabetologia; 2019 Jul; 62(7):1167-1172. PubMed ID: 30969375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.